Cargando…
Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645408/ https://www.ncbi.nlm.nih.gov/pubmed/33158455 http://dx.doi.org/10.1186/s13054-020-03362-y |
| _version_ | 1783606650537508864 |
|---|---|
| author | Asif, Sana Frithiof, Robert Lipcsey, Miklos Kristensen, Bjarne Alving, Kjell Hultström, Michael |
| author_facet | Asif, Sana Frithiof, Robert Lipcsey, Miklos Kristensen, Bjarne Alving, Kjell Hultström, Michael |
| author_sort | Asif, Sana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7645408 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76454082020-11-06 Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care Asif, Sana Frithiof, Robert Lipcsey, Miklos Kristensen, Bjarne Alving, Kjell Hultström, Michael Crit Care Research Letter BioMed Central 2020-11-06 /pmc/articles/PMC7645408/ /pubmed/33158455 http://dx.doi.org/10.1186/s13054-020-03362-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Research Letter Asif, Sana Frithiof, Robert Lipcsey, Miklos Kristensen, Bjarne Alving, Kjell Hultström, Michael Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care |
| title | Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care |
| title_full | Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care |
| title_fullStr | Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care |
| title_full_unstemmed | Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care |
| title_short | Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care |
| title_sort | weak anti-sars-cov-2 antibody response is associated with mortality in a swedish cohort of covid-19 patients in critical care |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645408/ https://www.ncbi.nlm.nih.gov/pubmed/33158455 http://dx.doi.org/10.1186/s13054-020-03362-y |
| work_keys_str_mv | AT asifsana weakantisarscov2antibodyresponseisassociatedwithmortalityinaswedishcohortofcovid19patientsincriticalcare AT frithiofrobert weakantisarscov2antibodyresponseisassociatedwithmortalityinaswedishcohortofcovid19patientsincriticalcare AT lipcseymiklos weakantisarscov2antibodyresponseisassociatedwithmortalityinaswedishcohortofcovid19patientsincriticalcare AT kristensenbjarne weakantisarscov2antibodyresponseisassociatedwithmortalityinaswedishcohortofcovid19patientsincriticalcare AT alvingkjell weakantisarscov2antibodyresponseisassociatedwithmortalityinaswedishcohortofcovid19patientsincriticalcare AT hultstrommichael weakantisarscov2antibodyresponseisassociatedwithmortalityinaswedishcohortofcovid19patientsincriticalcare |